Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzodiazepine SCHEMBL7160172 | 0.98 | GAA (0.44) | GAAMAPT | |
| Benzodiazepine SCHEMBL8137 | 0.98 | GAA (0.44) | GAAMAPT | |
| Benzodiazepine SCHEMBL4700331 | 0.96 | GAA (0.43) | GAAMAPT | |
| Benzodiazepine SCHEMBL11809777 | 0.96 | GAA (0.43) | GAAMAPT | |
| Benzodiazepine SCHEMBL4144041 | 0.96 | GAA (0.43) | GAAMAPT | |
| Benzodiazepine SCHEMBL11474576 | 0.96 | GAA (0.43) | GAAMAPT | |
| Benzodiazepine SCHEMBL936208 | 0.96 | GAA (0.43) | GAAMAPT | |
| Benzodiazepine SCHEMBL6618830 | 0.96 | GAA (0.43) | GAAMAPT | |
| Benzodiazepine SCHEMBL11484022 | 0.96 | GAA (0.43) | GAAMAPT | |
| Benzodiazepine SCHEMBL8139617 | 0.96 | GAA (0.43) | GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10251392-B2 | Antimicrobial devices and compositions | AVENT, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| US-20090035342-A1 | Antimicrobial Devices and Compositions | AVANOS MEDICAL SALES, LLC | 2009-02-05 | — | — | US | disclosed |
| EP-1781098-A2 | ANTIMICROBIAL DEVICES AND COMPOSITIONS | ACRYMED, INC. (US) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006015317-A2 | ANTIMICROBIAL DEVICES AND COMPOSITIONS | ACRYMED, INC. (US) | 2006-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10251392-B2 | Antimicrobial devices and compositions | AAAS, AOC1, COL14A1 | GAA 1128/4885MAPT 2314/4885 |
| US-20090035342-A1 | Antimicrobial Devices and Compositions | AAAS, AOC1, COL14A1 | GAA 1128/4885MAPT 2314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.